Mumbai (Maharashtra) [India], August 11 (ANI): Equity benchmark indices dipped during early hours on Wednesday despite stable global cues as the US Senate passed a one trillion dollar bipartisan infrastructure bill.
Baddi (Himachal Pradesh) [India], August 9 (ANI/Heylin Spark): Lifecare Neuro Products Ltd India is engaged in the manufacturing, marketing and export of pharmaceutical formulations.
Mumbai (Maharashtra) [India], August 3 (ANI): Equity benchmark indices traded higher during early hours on Tuesday bucking weak Asian trends with FMCG stocks gaining ground.
Mumbai (Maharashtra) [India], July 30 (ANI): Sun Pharmaceutical Industries on Friday posted a net profit of Rs 1,444 crore for the April to June quarter (Q1 FY22).
Mumbai (Maharashtra) [India], July 30 (ANI): Equity benchmark indices traded in a narrow range and wiped out early gains to close in the red on Friday amid weak global trends.
Mumbai (Maharashtra) [India], July 27 (ANI): Equity benchmark indices shaved early gains and closed half a per cent lower on Tuesday with pharma stocks being the worst sufferers.
Mumbai (Maharashtra) [India], May 28 (ANI): Key equity indices gained over half a per cent on Friday as the second Covid-19 wave continued to recede and investors expected the pace of vaccination to pick up.
Mumbai (Maharashtra) [India], May 28 (ANI): Equity indices gained over half a per cent during early hours on Friday as industry leaders hoped for another economic stimulus by the government.
Mumbai (Maharashtra) [India], May 27 (ANI): Sun Pharmaceutical Industries on Thursday posted 124 per cent increase in consolidated net profit at Rs 894 crore for the January to March quarter as compared to Rs 400 crore in the year-ago period.
Mumbai (Maharashtra) [India], May 17 (ANI): Equity benchmark gauges closed 1.7 per cent higher on Monday with banking and financial stocks witnessing substantial gains after a steady decline in fresh Covid-19 cases.
Mumbai (Maharashtra) [India], May 17 (ANI): Equity benchmark indices swung higher during early hours on Monday with private banks witnessing handsome gains.
New Delhi [India], May 10 (ANI): US pharmaceutical major Eli Lilly said on Monday it has issued royalty-free, non-exclusive voluntary licenses to Cipla, Lupin and Sun Pharmaceutical to accelerate and expand the availability of baricitinib in India for Covid-19 patients.